Rituximab for Obsessive-compulsive Disorder. (RITS-PO-2019)

Sponsor
Region Örebro County
Study ID
NCT03983031
Phase
PHASE1
Status
Completed

Conditions

  • Obsessive-Compulsive Disorder
  • Treatment Resistant Disorders

Eligibility Criteria

Sex
ALL
Age
18 Years - 40 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

This study evaluates the addition of rituximab to 12 patients diagnosed with treatment resistant obsessive-compulsive disorder in an open trial.

Key Dates

Start date
Aug 8, 2019
Status verified
May 2022
Primary completion
Mar 31, 2022
Completion
Mar 31, 2022

Study Design

Enrollment
11 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

Yale-Brown obsessive- compulsive scale (Y-BOCS) [ Time Frame: week 20 ]

Related Studies